ABBV · Healthcare
Abbvie Inc
38/100
Smart-money confidence1 of 3 sources positive
Below average interest
No standout activity across the feeds we track.
What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this
Hedge funds
50
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$468.4B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About ABBVIE INC
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products;…
Who's behind the signal
Every informed buyer we can see on ABBV, across all three feeds.
Hedge funds · 10
Glenview Capital Mgmt (Robbins)
New position
Point72 (Steve Cohen)
New position
Citadel Advisors
Increased +546%
D.E. Shaw & Co
Increased +212%
Millennium Management (Englander)
Increased +124%
AQR Capital Management
Increased +127%
+4 more in the full breakdown below ↓
Congress · 19
Josh Gottheimer
sold
Alan Armstrong
bought
Julie Johnson
sold
Julia Letlow
sold
Lisa C. McClain
sold
John Boozman
sold
Marjorie Taylor Greene
bought
Ritchie Torres
sold
+11 more in the full record below ↓
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 50 on record
Disclosures from 2023-08-14 to 2026-05-05
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-05-05 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2026-03-27 | Alan Armstrong · R-OK | Senate | Bought | $15,001 - $50,000 |
| 2025-12-18 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-12-08 | Julia Letlow · R-LA | House | Sold | $1,001 - $15,000 |
| 2025-11-13 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-10-31 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-10-30 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-10-30 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-08-22 | John Boozman · R-AR | Senate | Sold | $1,001 - $15,000 |
| 2025-08-14 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
Show the other 40
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2025-08-11 | John Boozman · R-AR | Senate | Sold | $1,001 - $15,000 |
| 2025-08-04 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-07-22 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-07-22 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-07-11 | Ritchie Torres · D-NY | House | Sold | $1,001 - $15,000 |
| 2025-06-17 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-05-22 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2025-05-15 | Robert P. Bresnahan, Jr. · R-PA | House | Bought | $1,001 - $15,000 |
| 2025-05-05 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-04-28 | Julia Letlow · R-LA | House | Bought | $1,001 - $15,000 |
| 2025-04-17 | Jefferson Shreve · R-IN | House | Sold | $50,001 - $100,000 |
| 2025-04-17 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2025-04-08 | Robert P. Bresnahan, Jr. · R-PA | House | Sold | $1,001 - $15,000 |
| 2025-04-07 | Jared Moskowitz · D-FL | House | Bought | $1,001 - $15,000 |
| 2025-04-03 | Dwight Evans · D-PA | House | Sold | $1,001 - $15,000 |
| 2025-04-03 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2025-04-01 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2025-03-17 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-02-25 | Robert P. Bresnahan, Jr. · R-PA | House | Bought | $1,001 - $15,000 |
| 2025-02-24 | Jefferson Shreve · R-IN | House | Bought | $50,001 - $100,000 |
| 2025-01-24 | Julia Letlow · R-LA | House | Sold | $1,001 - $15,000 |
| 2025-01-15 | Jared Moskowitz · D-FL | House | Bought | $1,001 - $15,000 |
| 2024-12-06 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2024-11-20 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2024-10-23 | Julia Letlow · R-LA | House | Bought | $1,001 - $15,000 |
| 2024-09-26 | Ritchie Torres · D-NY | House | Bought | $1,001 - $15,000 |
| 2024-09-04 | John James · R-MI | House | Sold | $1,001 - $15,000 |
| 2024-07-02 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2024-04-10 | Michael C. Burgess · R-TX | House | Sold | $1,001 - $15,000 |
| 2024-01-23 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2023-12-08 | Michael C. Burgess · R-TX | House | Sold | $1,001 - $15,000 |
| 2023-11-10 | John James · R-MI | House | Bought | $1,001 - $15,000 |
| 2023-11-08 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-10-24 | Greg Stanton · D-AZ | House | Sold | $1,001 - $15,000 |
| 2023-09-28 | Robert J. Wittman · R-VA | House | Sold | $1,001 - $15,000 |
| 2023-09-26 | Greg Stanton · D-AZ | House | Bought | $1,001 - $15,000 |
| 2023-09-08 | Lois Frankel · D-FL | House | Sold | $1,001 - $15,000 |
| 2023-09-06 | Lois Frankel · D-FL | House | Bought | $1,001 - $15,000 |
| 2023-08-30 | Lois Frankel · D-FL | House | Bought | $1,001 - $15,000 |
| 2023-08-14 | Michael C. Burgess · R-TX | House | Sold | $15,001 - $50,000 |
Not a model pick — but on our radar.
ABBVIE INC isn't in the top-10 model right now, but 10 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
10
Investors
2
New positions
5
Increasing
1
Decreasing
2
Unchanged
Price History
Loading price data...
A member of Congress bought
A member sold
Return:
High:
Low:
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.2×
% of portfolio
0.8%
Position change
NEW
0.8% of Glenview Capital Mgmt's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
NEW
0.1% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.5%
Position change
+546%
0.5% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.3%
Position change
+212%
0.3% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.3%
Position change
+124%
0.3% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
+127%
0.2% of AQR Capital Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+10%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.2%
Position change
—
0.2% of Polen Capital Management's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
−61%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.2×
% of portfolio
0.0%
Position change
—
0.0% of Dodge & Cox's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ABBVIE INC
Insider Trading (Form 4)
Recent trades by company officers and directors — filed within 2 days of each trade
Neutral
Sentiment
0
Buys
1
Sells
| Date | Insider | Title | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-14 | Donoghoe Nicholas | Insider | SELL | 32,710 | $250.00 | $8,177,500 |
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ABBVIE INC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime